Literature DB >> 15742391

Regulation of apoptosis by the papillomavirus E6 oncogene.

Ting-Ting Li1, Li-Na Zhao, Zhi-Guo Liu, Ying Han, Dai-Ming Fan.   

Abstract

Infection with human papillomaviruses is strongly associated with the development of multiple cancers including esophageal squamous cell carcinoma. The HPV E6 gene is essential for the oncogenic potential of HPV. The regulation of apoptosis by oncogene has been related to carcinogenesis closely; therefore, the modulation of E6 on cellular apoptosis has become a hot research topic recently. Inactivation of the pro-apoptotic tumor suppressor p53 by E6 is an important mechanism by which E6 promotes cell growth; it is expected that inactivation of p53 by E6 should lead to a reduction in cellular apoptosis, numerous studies showed that E6 could in fact sensitize cells to apoptosis. The molecular basis for apoptosis modulation by E6 is poorly understood. In this article, we will present an overview of observations and current understanding of molecular basis for E6-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15742391      PMCID: PMC4250780          DOI: 10.3748/wjg.v11.i7.931

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  107 in total

1.  More than one way to go.

Authors:  A H Wyllie; P Golstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

2.  Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity.

Authors:  Christina Kämmer; Ursula Warthorst; Norah Torrez-Martinez; Cosette M Wheeler; Herbert Pfister
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

3.  Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor.

Authors:  M A Steller; Z Zou; J T Schiller; R Baserga
Journal:  Cancer Res       Date:  1996-11-01       Impact factor: 12.701

4.  Telomerase activation and incidence of HPV in human gastrointestinal tumors in North Indian population.

Authors:  R C Sobti; J Kochar; K Singh; D Bhasin; N Capalash
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

5.  Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins.

Authors:  S Jackson; C Harwood; M Thomas; L Banks; A Storey
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

6.  HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes.

Authors:  J Alfandari; S Shnitman Magal; A Jackman; R Schlegel; P Gonen; L Sherman
Journal:  Virology       Date:  1999-05-10       Impact factor: 3.616

7.  Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.

Authors:  D S O'Connor; D Grossman; J Plescia; F Li; H Zhang; A Villa; S Tognin; P C Marchisio; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

8.  The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; P F Lambert
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Inhibition of Bak-induced apoptosis by HPV-18 E6.

Authors:  M Thomas; L Banks
Journal:  Oncogene       Date:  1998-12-10       Impact factor: 9.867

Review 10.  Viral modulators of cell death provide new links to old pathways.

Authors:  Pablo M Irusta; Ying-bei Chen; J Marie Hardwick
Journal:  Curr Opin Cell Biol       Date:  2003-12       Impact factor: 8.382

View more
  10 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Human Papillomavirus-mediated cervical cancer awareness and Gardasil vaccination: a pilot survey among North Indian women.

Authors:  Saumya Pandey
Journal:  J Community Health       Date:  2013-10

3.  Direct human papillomavirus E6 whole-cell enzyme-linked immunosorbent assay for objective measurement of E6 oncoproteins in cytology samples.

Authors:  Yi-Shan Yang; Karen Smith-McCune; Teresa M Darragh; Yvonne Lai; Ju-Hwa Lin; Ting-Chang Chang; Hsiao-Yun Guo; Tiea Kesler; Alicia Carter; Philip E Castle; Shuling Cheng
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

Review 4.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

5.  Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268.

Authors:  Michelle S Cespedes; Sarah L Kerns; Robert S Holzman; Paul J McLaren; Harry Ostrer; Judith A Aberg
Journal:  HIV Clin Trials       Date:  2013 Nov-Dec

Review 6.  Mitochondrial DNA mutations in human neoplasia.

Authors:  Anna M Czarnecka; Pawel Golik; Ewa Bartnik
Journal:  J Appl Genet       Date:  2006       Impact factor: 3.240

7.  Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoproteins.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Xuefeng Liu; Yuhai Dai; Dan P Hartmann; John Hanover; Richard Schlegel
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

Review 8.  Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.

Authors:  Niladri Ganguly; Suraj P Parihar
Journal:  J Biosci       Date:  2009-03       Impact factor: 1.826

9.  Comparison of Plasma Zinc Levels Among HIV+ and HIV- Subjects Infected with Condyloma Acuminata

Authors:  Anak Agung Gde Putra Wiraguna; Putu Indah Andriani; Made Swastika Adiguna
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

10.  Evidence of High-Risk Human Papillomavirus in Esophageal Cancer in East Azerbaijan Province, Northwest of Iran.

Authors:  Zahra Sadeghian; Hossein Bannazadeh Baghi; Vahdat Poortahmasebi; Javid Sadeghi; Alka Hasani; Arezoo Azadi; Mahin Ahangar Oskouee
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-01-07       Impact factor: 2.471

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.